Sarepta Therapeutics (SRPT) EV to EBITDA (2024 - 2026)
Sarepta Therapeutics' EV to EBITDA came in at 393.77 for Q1 2026.
Powered by 
Analysis
Sarepta Therapeutics (SRPT) EV to EBITDA (2024 - 2026) Analysis & Trends
Over the trailing twelve months to Mar 31, 2026, Sarepta Therapeutics reported EV to EBITDA of -226.78; for FY2024, it came in at 40.76.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Sarepta Therapeutics | 1.99 Bn | -1.25 Bn | 251.87 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 393.77 |
| Jun 30, 2025 | 21.69 |
| Dec 31, 2024 | 40.76 |
| Sep 30, 2024 | 89.65 |
| Jun 30, 2024 | 174.84 |
API Access
Sarepta Therapeutics EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SRPT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "SRPT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SRPT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();